Alterity Therapeutics (ATHE) Current Assets (2009 - 2026)

Alterity Therapeutics has reported Current Assets for 18 years, with the latest figure at $32.5 million in Q2 2026.

• On a quarterly basis, Current Assets rose 10.66% year-over-year to $32.5 million in Q2 2026; TTM through Jun 2026 was $32.5 million, a 10.66% increase from a year earlier, with the FY2026 full-year figure at $32.5 million, up 10.66% from the prior year.
• Current Assets was $32.5 million for Q2 2026 at Alterity Therapeutics, down from $37.3 million in the prior quarter.
• The five-year high for Current Assets was $37.3 million in Q4 2025, with the low at $190368.6 in Q2 2024.
• Average Current Assets over 5 years is $19.1 million, with a median of $21.8 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Assets sank 99.08% in 2023, then jumped 15331.87% in 2025.
• Over 5 years, Current Assets stood at $21.8 million in 2022, then plunged by 34.38% to $14.3 million in 2023, then sank by 52.35% to $6.8 million in 2024, then surged by 446.92% to $37.3 million in 2025, then declined by 12.86% to $32.5 million in 2026.
• The last three Current Assets figures came in at $32.5 million (Q2 2026), $37.3 million (Q4 2025), and $29.4 million (Q2 2025), per Business Quant data.